Few studies have examined the influence of perceived risk on breast screening behaviors among women with an increased familial breast cancer risk. This study included 1019 women aged 20-71 years from the Ontario site of the Breast Cancer Family Registry who had at least one first-degree relative diagnosed with breast and/or ovarian cancer. Information was obtained from a self-administered questionnaire completed at the time of recruitment and a follow-up telephone questionnaire. The associations between breast screening behaviors and perceived risk of developing breast cancer, measured on both a numerical and Likert-type verbal scale, were estimated using logistic regression analyses. Women who rated their risk of developing breast cancer as greater than 50% compared with less than 50% were significantly more likely to have a screening mammogram within the last 12 months (odds ratio: 1.91; 95% confidence interval: 1.15-3.16). Women were significantly more likely to have a screening mammogram (odds ratio: 1.82; 95% confidence interval:
Introduction
In Ontario in 2009, an estimated 8700 women were diagnosed with breast cancer and 2100 died of the disease (Canadian Cancer Society, 2009 ). Compared with women without a family history of breast cancer, the women with an affected first-degree relative are about twice as likely to develop breast cancer with the risk being higher when the relative was diagnosed before the age of 50 years, and when the number of diagnosed relatives increased (Pharoah et al., 1997; Collaborative Group on Hormonal Factors in Breast Cancer, 2001) . A recent review of randomized controlled trials has shown that screening mammography reduces breast cancer mortality (Humphrey et al., 2002) . Although this review did not differentiate effectiveness by familial breast cancer risk, others have shown that mammography and clinical breast examination (CBE) permit early breast cancer detection in women at higher familial risk of breast cancer (Kerlikowske et al., 2000; Halapy et al., 2004; Cortesi et al., 2006) . The Canadian Task Force on Preventive HealthCare recommends screening for breast cancer by mammography and CBE every 1-2 years for average-risk women aged 50-69 years (Morrison, 1994) . For high-risk women, annual breast screening examinations including mammogram, CBE, and breast self examinations (BSEs) are recommended before 50 years of age (Warner et al., 1999; Eccles et al., 2000; Evans and Lalloo, 2002) . Previous research has demonstrated that women with a first-degree relative who had been diagnosed with breast cancer are more likely to return for screening (Halabi et al., 2000; Bobo et al., 2004; Chiarelli et al., 2010) , and are more likely to start screening at an earlier age (Lux et al., 2005) when compared with women without a family history of breast cancer.
Perceived risk is an important concept in models explaining and predicting health behavior. Both the Health Belief and the Precaution Adoption Process models consider a woman's perceived risk of developing an illness as a precursor to preventive actions (Rosenstock, 1974; Weinstein and Sandman, 1992) . A recent metaanalysis reported that women with a family history of breast cancer were significantly more likely to perceive their risk of developing breast cancer as higher than other women and found a positive association between higher perceived risk and mammography screening (Katapodi et al., 2004) . However, most of the studies in the metaanalysis included women at an average risk.
Few studies have examined the association between perceived risk and breast cancer screening behaviors among women at an increased risk because of family history. Of the studies that used a numerical scale, one cross-sectional study of first-degree relatives of women diagnosed with breast cancer reported similar utilization of mammography and CBE, and slightly higher BSE practice in the past 1 or 2 years for women who reported a perceived lifetime risk of developing breast cancer of 50% or more compared with women who reported a perceived lifetime risk of developing breast cancer of less than 50% (Sheinfeld and Albert, 2003) . Another cross-sectional study of women attending a high-risk clinic, which compared women's perceived risk on a numerical scale with their actual risk, found no significant association between risk perception and compliance with mammography, although women who overestimated their risk of breast cancer had significantly poorer compliance with BSE (Lindberg and Wellisch, 2001) .
Other studies have used a verbal Likert-type scale to measure a woman's perceived risk of developing breast cancer. Cross-sectional studies of women attending genetic counseling (Isaacs et al., 2002) or with at least one affected first-degree relative (Lerman et al., 1993) found no significant association between perceived risk compared with other women of their age and adherence to mammography or CBE screening recommendations. In addition, both a prospective study that measured mammography uptake in the following year (Diefenbach et al., 1999) and a retrospective study that measured mammography and CBE in the past 3 years (Martin and Degner, 2006) found no significant association between perceived risk estimated on a Likert-type scale and screening uptake.
The majority of previous studies have not shown a positive association between perceived risk and breast screening behaviors among women with a higher familial risk. However, most of these studies included convenience samples of female relatives of patients with breast cancer attending genetic counseling and risk-assessment programs, and sample sizes were small. The purpose of this study was to examine the association between perceived risk of developing breast cancer, measured on both a numerical and a verbal scale, and breast screening behaviors among a large population cohort of women who had a least one first-degree relative diagnosed with breast and/or ovarian cancer.
Methods

Study population
This study identified a cohort of female relatives of incident cases of invasive breast cancer from the Ontario site of the Breast Cancer Family Registry (BCFR) funded by the US National Cancer Institute. The details of the BCFR and the Ontario site of the BCFR have been previously described (John et al., 2004) . In brief, cases of invasive breast cancer (probands), pathologically confirmed, and diagnosed between 1996 and 1998 were identified from the Ontario Cancer Registry. Physicians were contacted to obtain permission to mail their patients a Cancer Family History Questionnaire. Respondents meeting a defined set of family history criteria, and a random sample (25%) of those not meeting the criteria were asked to participate in the Ontario site of the BCFR. Of those eligible (N = 2587), 1851 (72%) probands participated.
These probands were asked for address information and permission to contact specific living relatives (first degree, those affected with breast, ovarian, or certain other cancers, and their first-degree relatives). An invitation letter to participate in the Ontario site of the BCFR was sent to relatives, and those who agreed to participate were mailed an Epidemiology Questionnaire (EQ) between 1998 and 2004. This study was conducted a few years after the initial recruitment of relatives. In this study, we identified all female relatives enrolled in the Ontario site of the BCFR who completed an EQ, were 20-69 years of age and alive at the start of the study, and were unaffected by breast cancer at the time of the proband's diagnosis date. From the 3374 participating female relatives, we identified 2066 (61%) who were residents of Ontario and of these, 1514 (73.3%) met our study criteria.
Of the 1514 women to whom a Personal History and Screening Questionnaire (PHSQ) was sent between November 2005 and March 2007, 1308 (86.4%) were contacted and 1112 (85.0%) consented to be interviewed. Further exclusions included 37 women who had a breast cancer diagnosis, 32 women who had only second-degree relatives with breast cancer, six women who had undergone a bilateral mastectomy, and 18 women who lacked information on their perceived breast cancer risk. The final study cohort consisted of 1019 women. This study was approved by the Research Ethic Boards of Mount Sinai Hospital and the University Health Network.
Data collection
Information was obtained from the EQ that was selfadministered during the recruitment of female relatives in the Ontario site of the BCFR and from a follow-up telephone questionnaire (PHSQ). The PHSQ updated changes in health behaviors and key demographic characteristics, as well as collecting detailed information on breast cancer screening examinations and perceived breast cancer risk. Eligible participants were sent a copy of the PHSQ and an introductory letter approximately 2 weeks before being contacted by phone. This allowed time for the participants to recall specific dates and events, and allowed them to refer back to the questionnaire during the interview.
The PHSQ asked two questions regarding perceived lifetime risk of developing breast cancer. The first question measured perceived risk on a numerical scale and asked 'On a scale from 0 to 100%, where 0 = certain not to happen and 100 = certain to happen, how likely are you to get breast cancer in your lifetime?' The second question assessed perceived risk on a verbal Likert-type scale and asked 'Compared with other women of your age, how likely are you to get breast cancer in your lifetime?' Responses were 'much below average, below average, same average risk, above average, or much above average'.
Mammography and CBE screening behaviors of the participants were characterized by reason and time since the last examination as derived from the PHSQ, which asked for the date (month and year) or age at last examination. The PHSQ also asked whether the main reason for the last mammogram and CBE was for screening ('part of a regular checkup', 'part of the Ontario Breast Screening Program', or due to a 'family history of breast cancer') or nonscreening purposes (due to a 'breast problem or symptom', 'follow-up of a previous breast problem', or 'participation in a research study'). Using the same information, another variable was created that considered time since last screening mammography and/ or CBE jointly. The frequency of conducting BSE was based on a PHSQ, which asked 'On average, how often do you examine your own breasts for lumps?' Responses were 'once a year or less, every 2-6 months, or once a month or more'. Another question that was asked was whether participants ever had a genetic test for the breast and ovarian cancer susceptibility genes BRCA1 or BRCA2.
Age at interview was calculated as the difference in years between the date of birth and the date of the PHSQ interview. Descriptive analyses used age categories of less than 40, 40-49, 50-59, and more than or equal to 60 years, but regression models were adjusted using age as a continuous variable. The highest level of education attained and the average annual frequency of visiting a healthcare facility in the past 2 years were determined using responses to the PHSQ. Body mass index of the participants in kg/m 2 was derived from information on height (EQ) and weight (PHSQ). Both the EQ and the PHSQ assessed earlier history of benign breast disease, with a positive history of benign breast disease being defined as a 'yes' response to either questionnaire.
The classification of family history risk of breast and/or ovarian cancer was based on information collected from the Family History Questionnaire completed by the relative's proband using a modified definition of previously referenced groups for familial breast cancer risk (Eccles et al., 2000; Cortesi et al., 2006) . Women were classified as having a low familial risk if they had only one first-degree relative diagnosed with breast cancer after the age of 40 years. Women were classified as having a moderate familial risk if they had (i) a self-reported Ashkenazi Jewish background; (ii) one first-degree relative with breast cancer diagnosed before the age of 40 years; (iii) one first-degree relative with ovarian cancer; or (iv) one first-degree relative with breast cancer diagnosed after the age of 40 years and two or more second-degree relatives with breast cancer. Finally, women were classified as having a high familial risk if they had (i) two or more first-degree relatives with breast and/or ovarian cancer diagnosed at any age; (ii) one or more first-degree relative(s) with both breast and ovarian cancer diagnosed at any age; (iii) one or more first-degree relative(s) diagnosed with bilateral breast cancer at any age; and/or (iv) a personal history of ovarian cancer.
Statistical methods
Chi-square tests assessed the association of perceived risk of developing breast cancer with each demographic or personal characteristic. Logistic and polytomous regression models were used to analyze screening behaviors with two or more than two levels, respectively, and perceived risk (Agresti, 2002) . Women with a perceived risk rated as 50% and greater than 50% were compared with the women with a perceived risk rated as less than 50%. Women with either above or much above average perceived risk were compared with those with much below, below, or same as average perceived risks. The least vigilant screening behavior categories were used as reference groups, and all models were adjusted for potential confounders. As many study participants were related and might share common cancer screening behaviors, a robust variance estimate was used to adjust for potential correlation due to family clustering (Binder, 1981; Morel, 1989) . All statistical analyses were conducted using SAS version 9.1 (SAS Institute Inc., 2004), and the significance of all statistical tests was evaluated using two-sided P values at a 5% level.
Results
Study participants completing the PHSQ included 1019 women from 639 unique families of which 394 (62%) had one family member, 159 (25%) had two family members, and 86 (13%) had three to eight family members. On the numerical scale, 230 (23.2%) women rated their perceived risk of developing breast cancer as below 50%, 251 (25.3%) rated their risk as 50%, 315 (31.7%) rated their risk as greater than 50%, but no more than 75%, and 196 women (19.8%) rated their risk as greater than 75% (Table 1) . We compared women who reported perceived risks above, below, and at 50%. Those with the highest estimates (>50%) were more likely to be younger (< age of 50 years), heavier (body mass index of >30 kg/m 2 ), and to seek healthcare more frequently (attend a healthcare facility at least twice annually).
In comparison with other women of the same age, 52 (5.3%) women perceived their risk of developing breast cancer as much below or below average, 290 (29.5%) perceived their risk as average, 548 (55.6%) perceived their risk as above average, and 95 (9.6%) perceived their risk as much above average (Table 2) . Compared with women who perceived a breast cancer risk of much below, below, or same as average, women who rated their risk as above or much above average were more likely to be younger than the age of 50 years, have a higher education (at least some postsecondary), and have visited a healthcare facility at least two times a year. The internal consistency estimate, measured using Cronbach's alpha, between the verbal and numerical perceived risk measures was 0.65.
Women who rated their risk as exactly 50% or greater than 50% were significantly more likely to have had a screening mammogram more than 12 months ago [odds ratio (OR): 2.41; 95% confidence interval (CI): 1.29-4.49 and OR: 1.94; 95% CI: 1.08-3.49, respectively] and within the last 12 months (OR: 2.09; 95% CI: 1.15-3.79 and OR: 1.91; 95% CI: 1.15-3.16, respectively) compared with women with a perceived risk of less than 50% (Table 3) . Women reporting a perceived risk of 50% were also more likely to have a screening CBE within the last 12 months (OR: 1.79; 95% CI: 0.82-3.92) or more than 12 months ago (OR = 1.97; 95% CI: 0.88-4.44), although these associations were not statistically significant. Having a greater frequency of monthly BSE or a genetic test for the presence of the BRCA1 or BRCA2 susceptibility genes did not seem to be significantly associated with perceived risk measured on a numerical scale.
Women who rated their risk as above or much above average were significantly more likely to have had a screening mammogram within the last 12 months (OR: 1.82; 95% CI: 1.17-2.81) and to perform BSE once a month or more (OR: 1.64; 95% CI: 1.02-2.63) compared with women who rated their risk as average or below (Table 4 ). No significant associations were observed between perceived risk measured on a verbal scale and having a screening CBE or ever having a genetic test for the breast cancer susceptibility genes.
Discussion
Overall, this study reported a positive association between perceived lifetime risk of developing breast cancer, measured either on a numerical or verbal scale, and breast screening among women who had at least one first-degree relative diagnosed with breast and/or ovarian cancer. Women who rated their risk as 50% or greater were more likely to have a screening mammogram compared with the women with a perceived risk of less than 50%, irrespective of time. In addition, women who rated their risk as above or much above average risk were significantly more likely to have had a mammogram in the past 12 months and more likely to practice BSE once a month or more compared with the women who rated their risk of developing breast cancer as the same as or below average. Our results show that women with a greater perceived risk of developing breast cancer, measured on a numerical or verbal scale, were almost twice as likely to have a screening mammogram, which differs from other cross-sectional studies of high-risk women. Previous cross-sectional studies examining perceived risk on a numerical or verbal scale have either observed a similar utilization of screening mammography among women with a perceived risk of 50% or more compared with less than 50% (Sheinfeld and Albert, 2003) , or have observed no significant association *P < 0.05 for perceived risk much below, below, and same as average vs. above and much above average. ***P < 0.0001 for perceived risk much below, below, and same as average vs. above and much above average. between risk perception and compliance with mammography (Lerman et al., 1993; Lindberg and Wellisch, 2001; Isaacs et al., 2002) . Both a prospective study that measured mammography uptake in the following year (Diefenbach et al., 1999) and a retrospective study (Martin and Degner, 2006) that measured mammography in the past 3 years did not report significant associations between perceived risk estimated on a verbal Likert-type scale that asked about the general likelihood of getting breast cancer someday during their lifetime and mammography uptake. Differences may have occurred because most of these studies had much smaller sample size than ours. In addition, many of the studies recruited convenience samples of women participating in high-risk clinics or genetic counseling that may have resulted in self-referral bias compared with this study that identified women from a population-based Familial Breast Registry.
Similar to this study, other investigations did not report a significant association between higher perceived risk measured on a numerical (Sheinfeld and Albert, 2003) or verbal scale (Isaacs et al., 2002; Martin and Degner, 2006) and having a screening CBE. However, this study did find that women who reported an above average perceived risk were significantly more likely to practice BSE once a month or more. One other cross-sectional study also observed slightly more frequent BSE perfor-mance in women with a perceived risk of 50% or more compared with less than 50%, although the difference was not statistically significant (Sheinfeld and Albert, 2003) . However, another study observed that women who overestimated their actual breast cancer risk on the numerical scale had significantly poorer self-reported compliance with BSE (Lindberg and Wellisch, 2001) . A few studies have examined performance of excessive BSEs (weekly or daily) in women with a first-degree relative with breast cancer. One study found that women were significantly more likely to perform excessive BSE if they perceived a risk that was higher or much higher compared with other women without family histories (Epstein et al., 1997) . Another study, using a perceived risk measure that encompassed both numerical and comparative estimates, also found that women who performed excessive BSE had significantly higher perceived risk (Brain et al., 1999) . These studies suggested that high-risk women might benefit from education about appropriate BSE technique to reduce their anxiety and tendencies to conduct excessive examinations.
In this study, elevated perceived risk measured on a numerical or verbal scale was not associated with having a genetic test for the BRCA1 or BRCA2 gene. This is likely because these genetic tests require physician referral based on family history of breast and/or ovarian cancer and our study adjusted perceived risk by the woman's familial risk of breast cancer. Although a meta-analytic review reported that women who perceive a higher breast cancer risk were more likely to pursue genetic testing (Katapodi et al., 2004) , the studies reviewed only examined interest in genetic testing or participation in genetic counseling. The only other study that, like this study, examined utilization of the genetic test also found a lack of significant association between perceived risk of breast cancer measured on a numerical scale and having a genetic test for the BRCA1 or BRCA2 genes in high-risk female participants (Lee et al., 2001) .
A few studies have suggested that a distinction should be made between whether perceived risk is measured on a numerical or verbal scale (Woloshin et al., 1999; Katapodi et al., 2004; Gurmankin Levy et al., 2006) . There are indications that women tend to overestimate their risk of developing breast cancer when asked on a numerical scale and underestimate their risk when asked to compare themselves on a verbal scale with their peers (Katapodi et al., 2004) . A recent study examined the utility of both the numerical and verbal measures, and results supported the utilization of both under different research objectives. Specifically, for identifying women with very high or very low risk perceptions, both measures performed well with the numerical scale having the higher specificity and the verbal scale having the higher sensitivity (Gurmankin Levy et al., 2006) . Generally, our results suggest that similar associations for breast cancer screening behaviors were found regardless of whether perceived risk was measured on the numerical or verbal scale.
This study had several strengths. First, this study included a large cohort of female relatives of breast cancer cases thus providing adequate power to examine associations. Second, participants were identified from a population-based cohort of breast cancer cases, which will have minimized self-referral bias. Third, as women who had undergone bilateral mastectomy might have appreciably different breast cancer screening practices, they were excluded from all analyses. This exclusion criterion was only applied in one previous study (Isaacs et al., 2002) . Another unique aspect of our study was that we measured perceived risk on both numerical and verbal scales.
Nevertheless, results from this study should be interpreted while considering the limitations. Given the crosssectional nature of our data, we were unable to determine the direction of the relationship between perceived risk and screening behaviors, that is, perceived risk may have been influenced by previous screening or educational experiences. Misclassification may have also occurred through the use of self-reported data to measure breast screening behaviors. Although self-reported mammography data have been found to be accurate for determining whether a woman has had a mammogram, self-reported data are less accurate in determining the time since last mammogram (Yang et al., 1998) , and women tend to underestimate the time since their last mammogram, resulting in an overestimation of recent mammography use (Degnan et al., 1992; Gordon et al., 1993) . To minimize recall inaccuracy, the PHSQ was mailed to the participants to allow recollection of dates and events before the telephone interview. To estimate the magnitude of recall bias, the self-reported date of the last mammogram was validated against medical records upon informed consent. Approximately 92% of women reported their last mammogram to be within 12 months from the actual date. Finally, the findings of this study may have limited generalizability to other populations. Participants in this study were family members of breast cancer cases identified from a population-based registry in the Canadian province of Ontario where universal healthcare coverage and an organized breast cancer screening program for women of 50 years of age or older are available.
An increased perceived risk of developing breast cancer measured on either numerical or verbal scales was significantly associated with having a screening mammogram within a large cohort of female relatives of women with breast cancer. These findings could inform educational messages and improve risk communication for women at an elevated familial breast cancer risk.
